BACH2 Gene as Potential Cancer Drug Target and Biomarker (G60468)

Target Name: BACH2

NCBI ID: G60468

BACH2

BACH2 Gene as Potential Cancer Drug Target and Biomarker

The search for new drug targets and biomarkers is a continuous process in the pharmaceutical industry. One of the promising targets in the field of cancer research is the BACH2 gene, which has been identified as a potential drug target and biomarker.

The BACH2 gene

The BACH2 gene is a member of the TGF-β signaling pathway, which plays a crucial role in cell growth, differentiation, and survival. The TGF-β pathway is a complex signaling pathway that involves the interaction of various proteins, including TGF-β1, TGF-β2, and BMP-1.

The BACH2 gene was identified as a critical regulator of TGF-β signaling in various organisms, including humans. The BACH2 gene has been shown to play a role in the regulation of cell proliferation, differentiation, and survival, and is associated with the development of various diseases, including cancer.

The potential drug target

The BACH2 gene has been identified as a potential drug target due to its involvement in the regulation of cell growth and survival. Several studies have shown that inhibition of the BACH2 gene has anti-cancer effects, including the inhibition of cell proliferation and the inhibition of the formation of blood vessels, which are critical for the growth and survival of cancer cells.

The BTB domain and CNC homolog 2

The BTB domain is a key region of the BACH2 gene that is involved in the regulation of TGF-β signaling. The BTB domain has been shown to interact with several proteins, including TGF-β1, TGF-β2, and BMP-1.

The CNC homolog 2 (CNC2) gene is a close relative of the BACH2 gene that is located in the same gene cluster. The CNC2 gene has been shown to interact with the BTB domain of the BACH2 gene, and may also be involved in the regulation of TGF-β signaling.

The potential biomarker

The BACH2 gene and its associated proteins have been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. The BACH2 gene has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed.

The BACH2 gene has been associated with the development of various diseases, including cancer, and has been shown to be involved in the regulation of the formation of blood vessels, which are critical for the growth and survival of cancer cells. Therefore, the BACH2 gene and its associated proteins may be useful as biomarkers for the diagnosis and treatment of cancer.

Conclusion

The BACH2 gene and its associated proteins have been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. The BACH2 gene has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed.

The potential drug target, BTB domain and CNC homolog 2, has been identified as a promising target for cancer treatment. The inhibition of the BACH2 gene and its associated proteins has been shown to have anti-cancer effects, including the inhibition of cell proliferation and the inhibition of the formation of blood vessels, which are critical for the growth and survival of cancer cells.

Therefore, the BACH2 gene and its associated proteins may be useful as biomarkers for the diagnosis and treatment of cancer, as well as potential drug targets for cancer treatment. Further research is needed to confirm the potential of these targets and to develop safe and effective therapies.

Protein Name: BTB Domain And CNC Homolog 2

Functions: Transcriptional regulator that acts as repressor or activator (By similarity). Binds to Maf recognition elements (MARE) (By similarity). Plays an important role in coordinating transcription activation and repression by MAFK (By similarity). Induces apoptosis in response to oxidative stress through repression of the antiapoptotic factor HMOX1 (PubMed:17018862). Positively regulates the nuclear import of actin (By similarity). Is a key regulator of adaptive immunity, crucial for the maintenance of regulatory T-cell function and B-cell maturation (PubMed:28530713)

The "BACH2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BACH2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets